S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How does the Consumer Price Index affect the stock market?
3 biotech powerhouses poised to thrive amid sector rebound
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Broadcom falls into a buy-the-dip opportunity 
A 'soft landing' or a recession? How each one might affect America's households and businesses
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How does the Consumer Price Index affect the stock market?
3 biotech powerhouses poised to thrive amid sector rebound
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Broadcom falls into a buy-the-dip opportunity 
A 'soft landing' or a recession? How each one might affect America's households and businesses
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How does the Consumer Price Index affect the stock market?
3 biotech powerhouses poised to thrive amid sector rebound
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Broadcom falls into a buy-the-dip opportunity 
A 'soft landing' or a recession? How each one might affect America's households and businesses
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How does the Consumer Price Index affect the stock market?
3 biotech powerhouses poised to thrive amid sector rebound
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Broadcom falls into a buy-the-dip opportunity 
A 'soft landing' or a recession? How each one might affect America's households and businesses
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities

Spero Therapeutics (SPRO) News Today

$1.32
+0.06 (+4.76%)
(As of 12/8/2023 ET)
Compare
Today's Range
$1.25
▼
$1.34
50-Day Range
$1.00
▼
$1.32
52-Week Range
$0.99
▼
$2.04
Volume
218,627 shs
Average Volume
158,257 shs
Market Capitalization
$69.96 million
P/E Ratio
132.00
Dividend Yield
N/A
Price Target
$7.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
finance.yahoo.com logoSpero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 14 at 1:01 PM
finanznachrichten.de logoSpero Therapeutics, Inc.: Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update
finanznachrichten.de - November 14 at 8:00 AM
benzinga.com logoRecap: Spero Therapeutics Q3 Earnings
benzinga.com - November 13 at 8:46 PM
finance.yahoo.com logoSpero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update
finance.yahoo.com - November 13 at 8:46 PM
msn.com logoSpero Therapeutics Q3 2023 Earnings Preview
msn.com - November 12 at 8:55 PM
markets.businessinsider.com logoHere's what Wall Street expects from Spero Therapeutics's earnings report
markets.businessinsider.com - November 12 at 3:30 PM
finance.yahoo.com logoSpero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
finance.yahoo.com - November 6 at 11:29 AM
businesswire.com logoSPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
businesswire.com - November 2 at 10:58 PM
finance.yahoo.com logoSpero Therapeutics to Present at Upcoming November Investor Conferences
finance.yahoo.com - November 1 at 8:43 PM
finanznachrichten.de logoSpero Therapeutics, Inc.: Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer
finanznachrichten.de - November 1 at 10:42 AM
finance.yahoo.com logoAll You Need to Know About Spero Therapeutics, Inc. (SPRO) Rating Upgrade to Buy
finance.yahoo.com - October 18 at 2:11 PM
finance.yahoo.com logoSpero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor Conference
finance.yahoo.com - September 20 at 8:20 PM
finance.yahoo.com logoInsider Sell: Chief Medical Officer Kamal Hamed Sells 39,496 Shares of Spero Therapeutics Inc
finance.yahoo.com - September 16 at 3:52 PM
finance.yahoo.com logoSpero Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 6 at 9:23 AM
markets.businessinsider.com logo4 Analysts Have This to Say About Spero Therapeutics
markets.businessinsider.com - September 5 at 6:22 PM
msn.com logoSpero Therapeutics (SPRO) Price Target Increased by 5.26% to 6.80
msn.com - August 31 at 8:21 PM
finance.yahoo.com logoSpero Therapeutics, Inc. (SPRO) Upgraded to Strong Buy: What Does It Mean for the Stock?
finance.yahoo.com - August 29 at 6:55 PM
finance.yahoo.com logoDown -11.72% in 4 Weeks, Here's Why Spero Therapeutics, Inc. (SPRO) Looks Ripe for a Turnaround
finance.yahoo.com - August 22 at 9:16 PM
nasdaq.com logoAlaunos (TCRT) to Wind Down Sole Clinical Study, Stock Dips 65%
nasdaq.com - August 16 at 2:15 PM
msn.com logoHC Wainwright & Co. Maintains Spero Therapeutics (SPRO) Buy Recommendation
msn.com - August 14 at 8:28 PM
markets.businessinsider.com logoHC Wainwright & Co. Maintains Buy Rating for Spero Therapeutics: Here's What You Need To Know
markets.businessinsider.com - August 14 at 3:26 PM
finance.yahoo.com logoSpero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 13 at 2:43 PM
finance.yahoo.com logoQ2 2023 Spero Therapeutics Inc Earnings Call
finance.yahoo.com - August 11 at 6:05 PM
finance.yahoo.com logoSpero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business Update
finance.yahoo.com - August 10 at 5:02 PM
markets.businessinsider.com logoSpero Therapeutics earnings: here's what Wall Street expects
markets.businessinsider.com - August 9 at 8:41 PM
finance.yahoo.com logoSpero Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
finance.yahoo.com - August 3 at 2:59 PM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on Spero Therapeutics (SPRO)
markets.businessinsider.com - August 1 at 7:44 PM
proactiveinvestors.com logoSpero Therapeutics shares rise on FDA approval of pivotal complicated UTI trial
proactiveinvestors.com - July 31 at 4:05 PM
marketwatch.com logoSpero Therapeutics in Special Protocol Assessment Agreement for Phase 3 Trial of Tebipenem HBr
marketwatch.com - July 31 at 11:04 AM
finance.yahoo.com logoSpero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr
finance.yahoo.com - July 31 at 11:04 AM
markets.businessinsider.com logoSpero Therapeutics (SPRO) Receives a Buy from H.C. Wainwright
markets.businessinsider.com - July 20 at 10:25 AM
ca.finance.yahoo.com logoSPRO - Spero Therapeutics, Inc.
ca.finance.yahoo.com - July 18 at 7:28 PM
finance.yahoo.com logoInvestors in Spero Therapeutics (NASDAQ:SPRO) have unfortunately lost 90% over the last three years
finance.yahoo.com - July 5 at 10:08 AM
finanznachrichten.de logoSpero Therapeutics, Inc.: Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finanznachrichten.de - July 1 at 8:27 AM
entrepreneur.com logo3 Pharma Stocks Every Investor Should Know
entrepreneur.com - June 15 at 1:08 PM
finanznachrichten.de logoSpero Therapeutics, Inc.: Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer
finanznachrichten.de - June 14 at 9:43 AM
bizjournals.com logoSpero CEO to step down; new CEO to turn focus toward lung disease antibiotic
bizjournals.com - June 14 at 9:43 AM
finance.yahoo.com logoSpero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer
finance.yahoo.com - June 14 at 9:43 AM
finance.yahoo.com logoTime To Worry? Analysts Are Downgrading Their Spero Therapeutics, Inc. (NASDAQ:SPRO) Outlook
finance.yahoo.com - May 18 at 7:51 AM
finance.yahoo.com logoSpero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2023 Earnings Call Transcript
finance.yahoo.com - May 16 at 3:26 PM
finance.yahoo.com logoQ1 2023 Spero Therapeutics Inc Earnings Call
finance.yahoo.com - May 12 at 9:04 AM
finanznachrichten.de logoSpero Therapeutics, Inc.: Spero Therapeutics Announces First Quarter 2023 Operating Results and Provides a Business Update
finanznachrichten.de - May 12 at 4:04 AM
msn.com logoRecap: Spero Therapeutics Q1 Earnings
msn.com - May 11 at 11:03 PM
finance.yahoo.com logoSpero Therapeutics Announces First Quarter 2023 Operating Results and Provides a Business Update
finance.yahoo.com - May 11 at 6:03 PM
seekingalpha.com logoSpero Therapeutics Q1 2023 Earnings Preview
seekingalpha.com - May 10 at 10:01 PM
msn.com logoSpero Therapeutics's Earnings Outlook
msn.com - May 10 at 4:54 PM
finance.yahoo.com logoSpero Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
finance.yahoo.com - May 4 at 9:58 AM
finance.yahoo.com logoSpero Therapeutics, Inc.'s (NASDAQ:SPRO) Price Is Right But Growth Is Lacking After Shares Rocket 26%
finance.yahoo.com - April 17 at 10:15 AM
finance.yahoo.com logoSpero Therapeutics to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious Diseases
finance.yahoo.com - April 14 at 8:11 AM
finance.yahoo.com logoIndustry Analysts Just Upgraded Their Spero Therapeutics, Inc. (NASDAQ:SPRO) Revenue Forecasts By 40%
finance.yahoo.com - April 13 at 10:53 AM
Get Spero Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPRO and its competitors with MarketBeat's FREE daily newsletter.



SPRO Media Mentions By Week

SPRO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SPRO
News Sentiment
▼
0.00

0.51
▲
Average
Medical
News Sentiment

SPRO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SPRO Articles
This Week
▼
0

1
▲
SPRO Articles
Average Week

Get Spero Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPRO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:SPRO) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -